Literature DB >> 6383673

Dosage of Cyclosporin A in children with renal transplants.

P F Hoyer, G Offner, K Wonigeit, J Brodehl, R Pichlmayr.   

Abstract

Results of Cyclosporin A (CyA) treatment following kidney transplantation in 16 children are reported. CyA was used in combination with low-dose prednisolone. The dosage of CyA was related to body surface area, starting with 500 mg/m2 daily and was reduced weekly by 50 mg/m2 until the maintenance dose of 300 mg/m2 was reached at the end of the fifth week. The dosage was controlled and adjusted by monitoring the CyA blood concentrations. In comparison with adults, children required higher CyA doses related to body weight to maintain the desired trough blood level range (200-750 ng/ml). In 16 children treated with CyA the graft function rate at three months was 100% and at six months 90%, because one patient died of septicemia. 10 patients experienced 20 reversible rejection episodes. Infectious complications and side-effects were similar to those observed in adults. Almost half of the patients exhibited transient nephrotoxicity which reversed after dose reduction. It is concluded that CyA treatment in a body surface area related dosage and in combination with blood level monitoring offers a successful way for kidney transplantation in childhood.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6383673

Source DB:  PubMed          Journal:  Clin Nephrol        ISSN: 0301-0430            Impact factor:   0.975


  20 in total

1.  20-year anniversary of Children's Hospital of the Medical School Hannover and paediatric transplantation.

Authors:  J Brodehl
Journal:  Eur J Pediatr       Date:  1992       Impact factor: 3.183

Review 2.  Pharmacokinetic drug interactions with cyclosporin (Part II).

Authors:  G C Yee; T R McGuire
Journal:  Clin Pharmacokinet       Date:  1990-11       Impact factor: 6.447

3.  Improved cadaveric renal transplant outcome in children.

Authors:  R B Ettenger; J T Rosenthal; J L Marik; M Malekzadeh; S B Forsythe; E S Kamil; I B Salusky; R N Fine
Journal:  Pediatr Nephrol       Date:  1991-01       Impact factor: 3.714

Review 4.  Clinically significant drug interactions with cyclosporin. An update.

Authors:  C Campana; M B Regazzi; I Buggia; M Molinaro
Journal:  Clin Pharmacokinet       Date:  1996-02       Impact factor: 6.447

Review 5.  Recent developments in dialysis and transplantation.

Authors:  D B Gradus; R N Fine
Journal:  Indian J Pediatr       Date:  1988 Jul-Aug       Impact factor: 1.967

6.  Renal handling of magnesium in transplanted children under cyclosporin A treatment.

Authors:  F Krull; P F Hoyer; G Offner; J Brodehl
Journal:  Eur J Pediatr       Date:  1988-11       Impact factor: 3.183

7.  Age effect on whole blood cyclosporine concentrations following oral administration in children with nephrotic syndrome.

Authors:  Katsumi Ushijima; Osamu Uemura; Takuji Yamada
Journal:  Eur J Pediatr       Date:  2011-11-26       Impact factor: 3.183

8.  Hypertension after renal transplantation in patients treated with cyclosporin and azathioprine.

Authors:  N Gordjani; G Offner; P F Hoyer; J Brodehl
Journal:  Arch Dis Child       Date:  1990-03       Impact factor: 3.791

9.  End stage renal failure: 14 years' experience of dialysis and renal transplantation.

Authors:  G Offner; C Aschendorff; P F Hoyer; H P Krohn; J H Ehrich; R Pichlmayr; J Brodehl
Journal:  Arch Dis Child       Date:  1988-02       Impact factor: 3.791

10.  The interaction of the calcium channel blockers verapamil and nifedipine with cyclosporin A in pediatric renal transplant patients.

Authors:  J F Crocker; K W Renton; T L LeVatte; D H McLellan
Journal:  Pediatr Nephrol       Date:  1994-08       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.